Germline mutations in familial haematopoietic malignancies identifies new pan-cancer predisposition genes and may alter clinical decision making, including for known cancer genes. NHMRC, Project Grant.
https://www.youtube.com/watch?v=Ep8_eA2meM0&feature=youtu.be
Biological characterisation and therapeutic options for high risk, DDX41 mutated, haematological malignancies. Beat Cancer Research Project Grant.
Research
Excludes commercial-in-confidence projects.
Germline mutations in familial haematopoietic malignancies identifies new pan-cancer predisposition genes and may alter clinical decision making, including for known cancer genes, NHMRC - Project Grant, 01/01/2019 - 31/12/2022
Biological characterisation and therapeutic options for high risk, DDX41 mutated, haematological malignancies, Cancer Council SA - Beat Cancer, 01/01/2018 - 31/12/2018
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2018 |
Open access
56
54
3
|
| 2017 |
80
73
|
| 2017 |
Open access
29
25
14
|
| 2015 |
9
10
|
| Year | Output |
|---|---|
| 2025 |
Open access
1
|
| 2025 |
5
2
|
| 2025 |
Open access
2
1
4
|
| 2025 |
Open access
2
2
|
| 2024 |
10
10
32
|
| 2024 |
Open access
1
|
| 2024 |
Open access
2
2
|
| 2024 |
Open access
10
10
|
| 2024 |
Open access
4
1
9
|
| 2024 |
Open access
1
1
|
| 2024 |
Open access
8
7
23
|
| 2023 |
14
13
|
| 2023 |
Open access
28
24
4
|
| 2023 |
Open access
2
2
1
|
| 2023 |
Open access
32
32
1
|
| 2023 |
Open access
3
3
1
|
| 2022 |
14
14
|
| 2022 |
38
29
181
|
| 2022 |
Open access
21
21
4
|
| 2022 |
Open access
15
14
|
| 2021 |
Open access
51
43
14
|
| 2021 |
Open access
11
9
39
|
| 2021 |
48
45
11
|
| 2020 |
Open access
129
117
5
|
| 2020 |
2
2
|
| 2020 |
Open access
80
72
|
| 2020 |
Open access
14
13
|
| 2020 |
Open access
3
3
1
|
| 2019 |
Open access
24
21
|
| 2019 |
Open access
17
15
|
| 2019 |
Open access
122
122
80
|
| 2018 |
Open access
55
54
|
| 2018 |
Open access
38
37
2
|
| 2018 |
Open access
168
157
8
|
| 2018 |
Open access
56
54
3
|
| 2017 |
Open access
6
6
3
|
| 2017 |
80
73
|
| 2017 |
6
3
|
| 2017 |
Open access
6
5
|
| 2017 |
Open access
12
11
4
|
| 2017 |
Open access
29
25
14
|
| 2016 |
Open access
31
23
1
|
| 2016 |
Open access
7
6
|
| 2015 |
9
10
|
| 2015 |
Open access
14
26
|
| 2014 |
Open access
107
93
|
| 2012 |
54
43
|
Research
Germline mutations in familial haematopoietic malignancies identifies new pan-cancer predisposition genes and may alter clinical decision making, including for known cancer genes. NHMRC, Project Grant.
https://www.youtube.com/watch?v=Ep8_eA2meM0&feature=youtu.be
Biological characterisation and therapeutic options for high risk, DDX41 mutated, haematological malignancies. Beat Cancer Research Project Grant.
External engagement & recognition
| Organisation | Country |
|---|---|
| Adaptive Biotechnologies | UNITED STATES |
| Auckland District Health Board | NEW ZEALAND |
| Austin Hospital | AUSTRALIA |
| Australian National University | AUSTRALIA |
| Box Hill Hospital | AUSTRALIA |
| Canberra Hospital | AUSTRALIA |
| Cardiff University | UNITED KINGDOM |
| Central Adelaide Local Health Network Incorporated | AUSTRALIA |
| de Duve Institute | BELGIUM |
| Eastern Health | AUSTRALIA |
| Federal University of Alagoas | BRAZIL |
| Flinders Medical Centre | AUSTRALIA |
| Flinders University | AUSTRALIA |
| Heidelberg University | GERMANY |
| Hudson Institute of Medical Research | AUSTRALIA |
| Imago Biosciences | UNITED STATES |
| Jarrett St Specialist Centre | AUSTRALIA |
| Lady Cilento Children's Hospital | AUSTRALIA |
| Mayo Clinic | UNITED STATES |
| Memorial Sloan-Kettering Cancer Center | UNITED STATES |
| MLL Münchner Leukämielabor GmbH | GERMANY |
| Monash University | AUSTRALIA |
| Murdoch Childrens Research Institute | AUSTRALIA |
| National Institutes of Health | MALAYSIA |
| Peter MacCallum Cancer Centre | AUSTRALIA |
| Queen Mary University of London | UNITED KINGDOM |
| Queensland Institute of Medical Research | AUSTRALIA |
| Radboud Institute for Molecular Life Sciences | NETHERLANDS |
| Royal Adelaide Hospital | AUSTRALIA |
| Royal Melbourne Hospital | AUSTRALIA |
| SA Pathology | AUSTRALIA |
| Semmelweis University | HUNGARY |
| Sir Charles Gardiner Hospital | AUSTRALIA |
| South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
| South Australian Health and Medical Institute | AUSTRALIA |
| St. Jude Children's Research Hospital | UNITED STATES |
| The Queen Elizabeth Hospital | AUSTRALIA |
| University Hospital Heidelberg | GERMANY |
| University of Adelaide | AUSTRALIA |
| University of Bergen | NORWAY |
| University of Bonn | GERMANY |
| University of Chicago | UNITED STATES |
| University of Melbourne | AUSTRALIA |
| University of Munich | GERMANY |
| University of New South Wales | AUSTRALIA |
| University of Oxford | UNITED KINGDOM |
| University of Paris | FRANCE |
| University of Queensland | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
| University of Washington | UNITED STATES |
| Uppsala University | SWEDEN |
| Waitemata District Health Board | NEW ZEALAND |
| Women's and Children's Hospital | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| 109455 - Examining the impact of environmental stressors and mutant microenvironment on disease development in models of inherited predisposition to haematological malignancies | Current |
| Examining the role of the pathogenic bone marrow microenvironment and hematopoietic stem cell stress in the development of leukaemia in blood cancer predisposition | Current |